Study Purpose: This research is looking at an investigational medication for adults with Spinocerebellar Ataxia (SCA). SCA is a condition that affects the brain and makes it hard to control movements.
Study Details: This trial is a randomized and double-blind study. This means that some participants will receive the investigational medication, while others will get a placebo (a substance with no active medication), and neither the participants nor the researchers will know who is getting which until the study is over. This helps ensure the results are fair and unbiased.
- Length of Study: The study will span several months, but the exact duration is not specified.
- Number of Visits: Participants will need to visit the study site multiple times. The exact number of visits is not specified.
- Eligibility: Participants must be adults diagnosed with Spinocerebellar Ataxia. Specific inclusion and exclusion criteria will apply to determine eligibility.
If you are an adult with SCA and are interested in participating, consider the time commitment and the nature of the trial before deciding. This is a chance to contribute to research that may help understand and potentially address SCA in the future.